Connection

Arnav Agarwal to Coronavirus Infections

Back to Details
This is a "connection" page, showing publications Arnav Agarwal has written about Coronavirus Infections.
Arnav Agarwal
Connection Strength
0.084
Coronavirus Infections
  1. A living WHO guideline on drugs for covid-19. BMJ. 2020 09 04; 370:m3379.
    View in: PubMed
    Score: 0.028
  2. High-flow nasal cannula for acute hypoxemic respiratory failure in patients with COVID-19: systematic reviews of effectiveness and its risks of aerosolization, dispersion, and infection transmission. Can J Anaesth. 2020 09; 67(9):1217-1248.
    View in: PubMed
    Score: 0.028
  3. Prognostic factors for severity and mortality in patients infected with COVID-19: A systematic review. PLoS One. 2020; 15(11):e0241955.
    View in: PubMed
    Score: 0.007
  4. The worldwide clinical trial research response to the COVID-19 pandemic - the first 100 days. F1000Res. 2020; 9:1193.
    View in: PubMed
    Score: 0.007
  5. Drug treatments for covid-19: living systematic review and network meta-analysis. BMJ. 2020 07 30; 370:m2980.
    View in: PubMed
    Score: 0.007
  6. Remdesivir for severe covid-19: a clinical practice guideline. BMJ. 2020 07 30; 370:m2924.
    View in: PubMed
    Score: 0.007
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.